Yinhu Li is an Associate Researcher and a Shenzhen Overseas High‑Level Talent. He received his B.Sc. in Biotechnology from Guizhou University in 2009, his M.Sc. in Biomedicine from the University of Edinburgh in 2010, and his Ph.D. in Computer Science from City University of Hong Kong in 2021.
From 2010 to 2018, he worked successively on bioinformatics analysis at BGI Tech Solutions Co., Ltd. and Shenzhen Microhealth Gene Tech Co., Ltd.
His research focuses on the gut-brain axis regulatory mechanisms in Alzheimer's disease.
1. Yinhu Li#, Xikang Feng#, Xuhua Chen#, Shuo Yang, Zicheng Zhao, Yu Chen*, Shuai Cheng Li*, PlasmidScope: a comprehensive plasmid database with rich annotations and online analytical tools. Nucleic Acids Research. 2025; 53(D1): D179–D188.
2. Yinhu Li#, Guangze Pan#, Shuai Wang#, Zhengtu Li, Ru Yang, Yiqi Jiang, Yu Chen*, Shuai Cheng Li*, Bairong Shen*: Comprehensive human respiratory genome catalogue underlies the high resolution and precision of the respiratory microbiome. Briefings in Bioinformatics. 2025; 26(1): bbae620.
3. Yijing Chen#, Yinhu Li#, Yingying Fan , Shuai Chen, Li Chen, Yuewen Chen, Yu Chen*: Gut microbiota-driven metabolic alterations reveal gut-brain communication in Alzheimer's disease model mice. Gut Microbes. 2024; 16(1): 2302310.
4. Yinhu Li#, Yijing Chen#, Yingying Fan, Yuewen Chen, Yu Chen*: Dynamic network modeling of gut microbiota during Alzheimer's disease progression in mice. Gut Microbes. 2023; 15(1): 2172672.
5. Yinhu Li#, Yiqi Jiang#, Zhengtu Li#, Yonghan Yu#, Jiaxing Chen, Wenlong Jia, Yen Kaow Ng, Feng Ye*, Shuai Cheng Li* , Bairong Shen*: Both simulation and sequencing data reveal coinfections with multiple SARS-CoV-2 variants in the COVID-19 pandemic. Computational and Structural Biotechnology Journal. 2022; 20: 1389-1401.
He has published more than 20 SCI papers and applied for more than 10 patents. He has led one General Program of the National Natural Science Foundation of China.